CAPR Net Income Growth
Capricor Therapeutics Inc · Net Income Growth
CAPR Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-84.94%period ending
CAPR TTM Net Income YoY % (30.11% → -84.94%)
Year-over-year change
High-resolution chart · PNG
CAPR net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -84.945% | |
| -108.1073% | |
| -159.5781% | |
| -140.3495% | |
| -150.3912% | |
| -126.4793% | |
| -81.5686% | |
| -16.639% | |
| 4.3806% | |
| 16.0732% | |
| 23.1981% | |
| -6.3924% | |
| -16.6749% | |
| -27.6835% | |
| -44.9345% | |
| -52.6333% | |
| -39.2567% | |
| -35.6644% | |
| -46.6097% | |
| -64.4966% | |
| -108.0675% | |
| -132.0465% | |
| -78.7237% | |
| -16.0784% | |
| 27.7202% | |
| 48.6628% | |
| 49.701% | |
| -2,628.6863% | |
| -774.239% | |
| -678.6892% | |
| -724.928% | |
| 102.5917% | |
| 110.4414% | |
| 113.3245% | |
| 112.9267% | |
| 18.3849% | |
| -11.6808% | |
| -33.4139% | |
| -46.2705% | |
| -54.1568% | |
| -51.0575% | |
| -60.8937% | |
| -106.8039% | |
| -33.1045% | |
| -17.1728% | |
| 2.3486% | |
| 30.0832% | |
| -79.4532% | |
| -125.5773% | |
| -242.2078% | |
| -369.705% | |
| -42.7372% | |
| 3.1187% | |
| 43.1004% | |
| 61.2466% | |
| 16.4772% | |
| 16% | |
| 15.7689% | |
| 19.0153% | |
| 40.9438% | |
| 33.3143% | |
| 34.0145% | |
| 23.3837% | |
| 26.7184% | |
| 33.6076% | |
| 32.2815% | |
| 40.0472% | |
| 26.7635% | |
| 29.0316% | |
| 5.9664% | |
| -27.4704% | |
| -62.5891% | |
| -386.7842% | |
| -692.6371% | |
| -1,125.8842% | |
| -830.9328% | |
| -11,329.3022% | |
| -7,579.9565% | |
| -4,355.6121% | |
| -3,876.5589% | |
| -26.7174% | |
| 1.709% | |
| -3.946% | |
| -47.6959% | |
| -95.3059% | |
| -41.2431% | |
| -12.3043% | |
| 1.9464% | |
| 52.9887% | |
| 41.5068% | |
| -3.6569% | |
| 0.717% | |
| -112.7148% | |
| -265.8106% | |
| 30.1125% |